21. November 2009 00:40
Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical School and neurologist at the Massachusetts General Hospital in Boston, on Thursday, November 19, presented his laboratory's research on the new field of study called "Connectivity" at the launch of the MINDlink Foundation.
[More]
20. November 2009 04:39
Research and Markets (http://www.researchandmarkets.com/research/fae4d4/neurological_disea) has announced the addition of Decision Resources, Inc.'s new report "Neurological Disease: Early-Stage R&D and Dealmaking" to their offering.
[More]
20. November 2009 03:16
Research and Markets (http://www.researchandmarkets.com/research/60b63b/the_pricing_and_re) has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering.
[More]
20. November 2009 02:41
Research and Markets (http://www.researchandmarkets.com/research/410c60/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - A US and European Market Analysis" report to their offering.
[More]
695b9412-1af5-4d8a-a9fc-d0801585eab5|0|.0
Posted in: Pharmaceutical News
Tags: Antibody, Brain, Brain Cancer, Cancer, Cell, Ciprofloxacin, Follicular Lymphoma, Lung Cancer, Lymphoma, Nephrology, Neurology, Nuclear Medicine, Oncology, Radiation Therapy, Radiotherapy, Zevalin
20. November 2009 00:55
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
[More]
20. November 2009 00:24
For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. In fact, the researchers were not able to detect any long-term cognitive declines attributable to surgery in a group of 575 patients they studied.
[More]
20. November 2009 00:04
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.
[More]
19. November 2009 23:09
Virtanen has developed a method for analysing snoring sounds by using a PC with a microphone connection and a wireless microphone. The objective was to create an application that could be used at home to monitor snoring. By utilizing this technology, researchers from Tampere University of Technology and the University of Helsinki have investigated sleep disorders and further refined related screening technologies.
[More]
19. November 2009 11:48
CleveMed recently received ISO 13485 certification issued by BSI Management Systems America Inc., one of the foremost auditing bodies in the world. CleveMed has also received the CE Mark and CMDCAS allowing its products to be distributed to the large European and the Canadian markets which will strengthen its worldwide market presence.
[More]
19. November 2009 06:55
Research and Markets (http://www.researchandmarkets.com/research/d3e55b/pediatric_board_re) has announced the addition of the "Pediatric Board Review" report to their offering.
[More]
d4ec9abc-91de-438c-89da-9ba0d7241de0|0|.0
Posted in: Child Health News
Tags: Allergy, Autism, Biochemistry, Cardiology, Dermatology, Education, Endocrinology, Gastroenterology, Genetics, Hematology, Hospital, Immunology, Learning Disability, Metabolism, Nephrology, Neurology, Nutrition, Obstetrics, Oncology, Ophthalmology, Orthopedic, Pediatrics, Psychiatry, Radiology, Rheumatology, Sports Medicine
19. November 2009 06:30
Visually impaired people appear to be fearless, navigating busy sidewalks and crosswalks, safely finding their way using nothing more than a cane as a guide. The reason they can do this, researchers suggest, is that in at least some circumstances, blindness can heighten other senses, helping individuals adapt.
[More]
19. November 2009 03:32
Physicians for Social Responsibility today released a groundbreaking medical report, "Coal's Assault on Human Health," which takes a new look at the devastating impacts of coal on the human body.
[More]
2ba1f35f-cd1c-4dcb-a60a-6d3c2250c3a9|0|.0
Posted in: Healthcare News
Tags: Arsenic, Asthma, Cancer, Cardiovascular Disease, Congestive Heart Failure, Food Production, Heart Failure, Lung Cancer, Malaria, Manganese, Nervous System, Neurology, Pollution, Stroke
19. November 2009 01:42
Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries.
[More]
234d5eb2-35a6-4162-8012-1ce935422d94|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Acne, Alzheimer's Disease, Dermatology, Diarrhea, Dystonia, Headache, Hygiene, Hypercholesterolemia, Hyperglycemia, Neurology, Parkinson's Disease, Podiatry, Stroke, Tinnitus
19. November 2009 00:55
There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS.
[More]
88745bdd-ced7-4029-aac6-087acf42e621|0|.0
Posted in: Medical Condition News | Women's Health News
Tags: Alzheimer's Disease, Blood Pressure, Brain, Diabetes, Epilepsy, Gestational Diabetes, Multiple Sclerosis, Nervous System, Neurology, Neuroscience, Parkinson's Disease, Pregnancy, Stroke, Ultrasound
18. November 2009 04:43
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body.
[More]
50d53b19-1261-4af8-9034-c4c1c09f6f70|0|.0
Posted in: Medical Procedure News | Medical Condition News
Tags: Avastin, Bevacizumab, Biopsy, Blood Vessel, Bone, Bone Marrow, Brain, Brain Cancer, Brain Tumor, Cancer, Cervical Cancer, Deep Brain Stimulation, Drug Delivery, Education, Gene Therapy, Glioblastoma, Glioblastoma Multiforme, Hospital, Neurology, Oncology, Parkinson's Disease, Penicillin, Pregnancy, Radiology, Spine
Subscribe